It does not contain information regarding stroke subtype, comorbidities that may increase a patient’s risk of stroke (e.g., smoking, hypertension), biomarkers (e.g., prothrombin time, D-dimer levels), or the full extent of their treatment. Here, F2 is linked to hypertensive disorder.